Literature DB >> 10496097

[An outbreak of Legionnaire's disease associated with a Japanese spa].

T Nakadate1, K Yamauchi, H Inoue.   

Abstract

From June 24 to July 5, 1996, 3 patients were admitted to the same hospital with atypical pneumonia. One of the patients, a 52-year-old man, demonstrated progressive pulmonary infiltrates and severe hypoxemia, and finally required mechanical ventilation. All 3 patients had elevated antibody titers for Legionella pneumophila serogroup 1, and had visited the same spa prior to the onset of their symptoms. On September 25, 1996 the district health department inspected the spa, and isolated Legionella pneumophila serogroup 1 from the facility's hot water tanks and outlets. Although it has been reported that many spas in Japan are contaminated with Legionellaceae, the outbreak we encountered suggests that Japanese spas, like whirlpool spas in Europe and North America, can be a source of Legionnaire's disease.

Entities:  

Mesh:

Year:  1999        PMID: 10496097

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Specific detection of viable Legionella cells by combined use of photoactivated ethidium monoazide and PCR/real-time PCR.

Authors:  Bin Chang; Kanji Sugiyama; Toshitsugu Taguri; Junko Amemura-Maekawa; Fumiaki Kura; Haruo Watanabe
Journal:  Appl Environ Microbiol       Date:  2008-10-31       Impact factor: 4.792

2.  Rapid enumeration of active Legionella pneumophila in freshwater environments by the microcolony method combined with direct fluorescent antibody staining.

Authors:  Takashi Baba; Naoko Inoue; Nobuyasu Yamaguchi; Masao Nasu
Journal:  Microbes Environ       Date:  2012-03-23       Impact factor: 2.912

3.  Legionellosis Associated with Recreational Waters: A Systematic Review of Cases and Outbreaks in Swimming Pools, Spa Pools, and Similar Environments.

Authors:  Erica Leoni; Federica Catalani; Sofia Marini; Laura Dallolio
Journal:  Int J Environ Res Public Health       Date:  2018-07-30       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.